A clinical trial investigating the use of two different strengths of acetic acid in treating infected burn wounds.
- Conditions
- Colonised burn woundsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]MedDRA version: 20.1 Level: PT Classification code 10053615 Term: Thermal burn System Organ Class: 10022117 - Injury, poisoning and procedural complicationsMedDRA version: 20.0 Level: PT Classification code 10051548 Term: Burn infection System Organ Class: 10021881 - Infections and infestations
- Registration Number
- EUCTR2017-003481-28-GB
- Lead Sponsor
- niversity Hospitals Birmingham NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Not specified
- Target Recruitment
- 20
1. Patient to have a 1 - <10% TBSA burn injury prior to enrolment
2. Burn wound colonised with a specifically identifiable bacteria
3. Patients aged =18 years old
4. Patients who are anticipated to remain as inpatients for the study duration i.e. 5 days
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 15
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 5
1. Patients who lack capacity to give informed consent (NB: translation services will be available for non-English speaking patients)
2. Patients who are receiving systemic antibiotics
3. Patients with burns solely to the face and/or genital area
4. Patients who have received acetic acid as part of standard therapy upon admission to inpatients for this burn injury
5. Patients deemed unsuitable to enter trial in the opinion of the investigator
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method